Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Lazzaro Medical Announces Know-How Agreement with Mayo Clinic


“In the United States, TBM is estimated to be present in half of the nation’s 16 million COPD patients. Previous treatment was worse than the disease for many potential patients,” said Dr. Richard Lazzaro, Co-Founder and Chief Medical Officer of Lazzaro Medical. “Through this collaboration, we seek to reduce timelines in making this therapy available for the millions of patients who could greatly benefit.”

Resources from this agreement will also be used to prepare the company’s 510k FDA submission.

“We are proud to collaborate with Mayo Clinic in our shared goal of improving patient care and addressing the most common disease you’ve likely never heard of, TBM.” said Pete Wehrly, CEO of Lazzaro Medical. “We hope to educate patients more rapidly about the disease, drive awareness of the procedure and impact millions of patients, all while continuing to grow our platform.”

Mayo Clinic has research and financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.

ABOUT TRACHEOBRONCHOMALACIA

Tracheobronchomalacia, known as TBM, is a degenerative disease that causes the complete, or near-complete, collapse of the airway due to the breakdown of cartilage in the trachea. Often masquerading as chronic cough and/or shortness of breath, even after prescribed medications, it progressively worsens, often along with bouts of pneumonia and other respiratory infections. This leads to a significantly reduced quality of life, and even death, if left untreated. Although TBM is a vastly underdiagnosed disease, the prevalence has been estimated to be as high as 10% in the general population– with approximately half of the nation’s 16 million COPD patients also likely suffering from TBM.

ABOUT LAZARRO MEDICAL

Lazzaro Medical is a Boulder, Colorado-based medical device company on a mission to restore healthy breathing in millions of people suffering from tracheal and bronchial maladies with a transformative platform of life-changing, minimally-invasive, robotic procedures, devices, and diagnostics. Co-Founded by Dr. Richard Lazzaro, a world-renowned thoracic surgeon with 35 years of specialized expertise in minimally invasive and robotic thoracic surgery, the company’s platform is based off his groundbreaking firsts in robotic thoracic surgery and his leading the largest tracheobronchomalacia (TBM) programs in the nation. For more information on Lazzaro Medical, please visit Lazzaromed.com, or follow @Lazzaro Medical on LinkedIn.

Media Contact

Renee Israel, Lazzaro Medical, 1 9175935100, [email protected], https://lazzaromed.com

SOURCE Lazzaro Medical

Shearwater Health Welcomes New CHRO to the Executive Team


Nashville-based Shearwater Health has trained and augmented care teams with remote and onsite clinicians since 1973, reducing the strain on the healthcare system. With a global workforce of more than 5,000 expertly trained, clinical resources supported by innovative technology and Six Sigma process excellence, Shearwater Health offers both remote and onsite clinical expertise that can be deployed rapidly and securely. The organization recruits and trains nurses in skills such as utilization management, care management, patient care, and revenue cycle and supports their careers through education including the US Nursing Licensure Exam.

“Jen brings extensive experience in HR management, driving transformational change with a significant focus on building effective HR programs,” said Tom Kendrot, chief executive officer of Shearwater Health. “Our continued impact addressing worldwide nursing shortages depends on attracting and retaining the best talent, both in the US and overseas. We are thrilled to welcome a leader like Jen to the team.”

About Shearwater Health

Shearwater Health provides teams of remote and onsite clinicians that expand the size and impact of clinical teams so that clients can focus on internal teams practicing at the peak of their license. From bedside to back-office, there are over 5,000 Shearwater clinicians solving medical and administrative problems every hour of every day all over the world. Shearwater combines clinical expertise with Six Sigma process excellence and RPA technology to improve healthcare outcomes. For more information, please visit https://shearwaterhealth.com/ or on Linked In.

Media Contact

Heather Rivenburg, Punching Nun Group, 1 703-216-3893, [email protected], https://punchingnungroup.com/

SOURCE Shearwater Health

Critical Conversations in Cloud Computing


“Cloud computing has in many ways become a cornerstone in Bio-IT, particularly within startup and emerging firms seeking to harness the power of flexible, scalable infrastructure to improve collaboration, optimize costs, and accelerate drug discovery and development processes,” said Michael Riener, CEO of RCH Solutions and series moderator. “With ‘Elevated Perspectives,’ we hope to address the specific challenges many of these organizations face when planning, building, or maintaining these mission-critical environments, and provide proven tips to help them navigate the Cloud landscape effectively.”

Though Cloud technology has become increasingly vital for Life Sciences organizations, many firms—particularly start-up and emerging organizations—face challenges as they look to implement and mature their Cloud environment for growth and scale.

Each episode in the series is roughly 30 minutes or less and will offer scientist-led teams and their Bio-IT counterparts strategic insights and technical best practices on a range of Cloud topics, including data management, security, cost optimization, and more.

“All based on years of hands-on experience, the episodes are quick, the conversations are lively, and the intel is practical and intended to be applied right away,” Reiner continued.

Anchored by industry veteran technologist and RCH’s CTO, Phil Eschallier, each episode will feature technical and business experts from Cloud leader Amazon Web Services (AWS) and others driving innovation in the Cloud. The first four episodes will feature:

“Amidst this boundary-breaking landscape, Cloud computing is a powerful catalyst for progress. ‘Elevated Perspectives’ is our commitment to equip Life Sciences organizations, especially start-ups and emerging firms, with the knowledge and tools they need to embrace the Cloud’s transformative potential.”

To watch the first episodes of Elevated Perspectives visit http://www.rchsolutions.com/elevated-perspectives

About RCH Solutions:
RCH Solutions (RCH) is a global provider of Bio-IT expertise, helping Life Sciences and Healthcare companies of all sizes clear the path to discovery. For more than 30 years, RCH has provided focused experience and unmatched specialization designing and deploying cross-functional IT strategies, supporting R&D infrastructure, and offering workflow best practices that solve enterprise and scientific computing challenges. Learn more at http://www.rchsolutions.com

Media Contact

Melissa Thomas, For RCH Solutions, 215.499.9788, [email protected], www.rchsolutions.com 

LinkedIn

SOURCE RCH Solutions

Mindray Exhibiting at ANESTHESIOLOGY® Annual Meeting


“We recognize the human side of healthcare and clinician’s role in providing best-in-class patient care, which is why we create products suited to your clinical needs in this environment,” said Melanie Rosen, Sr. Marketing Manager, Perioperative Solutions. Rosen continued, “We are excited to showcase our complete perioperative solutions at ANESTHESIOLOGY® Annual Meeting and invite all attendees to stop by Booth 1026 in Moscone Center South and witness how we advance medical technologies to make healthcare more accessible.”

During the assembly, Mindray will offer multiple educational events presented by renowned anesthesia leaders. On Saturday at 12:30 pm, Mindray is sponsoring the Center Stage Feature Presentation by Daniel Talmor, MD MPH, presenting on Lung Protective Ventilation in the Operating Room. Mindray will also host Dr. Richard Teames and Basem J Abdelmalak, MD, FASA, SAMBA-F, on Saturday and Sunday in Booth 1026 for educational sessions.

Mindray understands the need for clinicians to deliver focused and efficient patient care in the Perioperative space. With over 30 years of experience, Mindray has deep-seated roots and a sole focus on the healthcare industry. Through years of innovation, Mindray offers a comprehensive portfolio of leading-edge solutions to meet the diverse demands of evolving patient populations. These innovative, accessible solutions offer sophisticated tools and technologies that offer meaningful innovation to drive impactful results, complementing clinical workflow and enhancing patient care in the operating room.

About Mindray
Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: medical imaging, patient monitoring and life support, and in-vitro diagnostics. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in Silicon Valley, California, with additional facilities in major international markets around the world. For more information, please visit Mindray.com.

Media Contact

Sondra Kaufman, Mindray North America, 201.995.8047, [email protected]

Twitter Facebook LinkedIn

SOURCE Mindray North America



Sublingual Immunotherapy May Result in Desensitization and Remission for Peanut-Allergic Children


After 36 months of treatment, participants who were desensitized to at least 443 mg of peanut protein discontinued therapy for three months and then underwent an additional assessment for remission. Upon assessment, 60% of children in the study were found to experience desensitization to peanut protein, and 48% experienced remission three months after therapy. None of the placebo participants naturally outgrew their peanut allergy, and remission was seen only in the sublingual immunotherapy (SLIT) participants.

“Early childhood is a time when a child’s immune system is most adaptable. We are excited that peanut sublingual immunotherapy (SLIT) seems to be able to take advantage of this adaptability with not only the strongest desensitization that we have seen to date, but also the potential for 3-month remission of the peanut allergy” said Edwin Kim, MD, MS corresponding author for the study.

Higher rates of desensitization and remission were found in the group of 1- 2-year-old participants compared to the 2-3-year-old group and 3- 4-year-old group, which supports an advantage to early intervention.

Most side effects of the treatment were shown to have little difference between the placebo group and the immunotherapy group of participants, with the exception of “oropharyngeal itching.” The research noted oropharyngeal itching as the most common side effect, affecting 80% of peanut sublingual immunotherapy (SLIT) participants compared to only 28% of placebo participants, although no symptoms required epinephrine for participants. “The percentage of participants reporting skin, gastrointestinal, upper respiratory, lower respiratory or multi-system symptoms was not significantly different between peanut SLIT and placebo participants,” according to the study.

While larger trials are necessary to validate the findings, the results of the study are promising and suggest that early intervention with peanut sublingual immunotherapy (SLIT) warrants further exploration.

Read the full study

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists, allied health professionals and other professionals with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries and is the go-to resource for patients living with allergies, asthma and immune deficiency disorders.

Media Contact

Candace Archie, The American Academy of Allergy, Asthma & Immunology, (414) 272-6071, [email protected]

SOURCE The American Academy of Allergy, Asthma & Immunology

HR Pharmaceuticals, Inc. significantly expands the TruCath® portfolio with two new offerings of ready-to-use intermittent catheters delivering optimal protection, comfort, and convenience



YORK, Pa., Oct. 10, 2023 /PRNewswire/ — Today, HR Pharmaceuticals, Inc. (HRP) announced the introduction of two ready-to-use intermittent catheter offerings, TruCath Swift™, and TruCath Oasis™, broadening the TruCath® product range to deliver a comprehensive selection of products to meet…

MyAdvisor Named 2023 Best Place to Work PA by Central Penn Business Journal and Lehigh Valley Business


“This award comes as an uplifting affirmation of the work we’re doing,” said MyAdvisor President Jennifer Christman. “As a company that strives on providing comprehensive support for our clients around the country, we’re equally happy to know that we’re able to provide our own employees with similar empowerment.”

Recently MyAdvisor was also awarded the 2022-2023 Gold Level Bell Seal for Workplace Mental Health by Mental Health America (MHA). The Bell Seal is a first-of-its-kind workplace mental health certification that recognizes employers who strive to create mentally healthy workplaces for their employees.

Best Places to Work in PA identifies, recognizes, and honors the best places of employment in Pennsylvania in three categories: small employer (15-99 employees), medium employer (100-249) and large employer (250 or more). There were two parts used to determine the rankings. The first consisted of evaluating each nominated company’s workplace policies, practices and demographics, worth approximately 25% of the total evaluation. The second part consisted of an employee survey to measure the employee experience, which consisted of 75% of the total. The combined scores determined the top companies and the final ranking.

The final rankings will be announced at the Dec. 7 awards ceremony that will take place at the Lancaster Marriott at Penn Square Hotel.

“This year’s 2023 Best Places to Work in PA winners make sure their teams feel appreciated, engaged and challenged. They foster a positive environment for innovative teams to thrive,” said Suzanne Fischer-Huettner, managing director of BridgeTower Media/Central Penn Business Journal and Lehigh Valley Business. “These companies demonstrate consistent communication and recognize good work, important hallmarks of a great place to work. We at the Central Penn Business Journal and Lehigh Valley Business are pleased to join the Best Companies Group in celebrating this year’s honorees.”

Winners will be profiled in a publication that will be inserted into the Dec. 8 issue of Central Penn Business Journal and also distributed in the Dec. 18 issue of Lehigh Valley Business. The magazine will be available online at CPBJ.com. and LVB.com.

About MyAdvisor

Founded in 2007, MyAdvisor® provides holistic care to all those who provide service and their family members, with access to one-on-one care coordination and employee assistance programs which incorporate behavioral health, wellness, navigational advocacy, financial literacy and career development. MyAdvisor also includes VetAdvisor®, an American Association of Suicidology (AAS) accredited program, with over a decade of experience in health and wellness serving military veterans, active duty service members, national guardsmen and reservists.

About the Central Penn Business Journal

Central Penn Business Journal is the leading source of business news and information in Central Pennsylvania for the past 39 years. In addition to breaking news on its multimedia news site at CPBJ.com, it also publishes a biweekly print edition. Central Penn Business Journal publishes various special focus sections on topics such as real estate and construction and mergers and acquisitions in addition to the yearly Book of Lists. It also hosts 10 annual events, including Women of Influence, Reader Rankings, Fastest Growing Companies and Best Places to Work in PA, to recognize excellence and provide leadership opportunities. In addition, the Central Penn Business Journal facilitates webinars bringing local experts from the business community together to discuss current topics and trends. Its Digital Marketing Solutions helps customers with social media, search engine marketing and optimization, retargeting, email marketing and more. Central Penn Business Journal and its sister publication, Lehigh Valley Business, which covers business in the Lehigh Valley, are part of BridgeTower Media, the leading provider of B2B information, research, events and marketing solutions across more than 25 U.S. markets and industries.

About Lehigh Valley Business

Lehigh Valley Business is a multimedia news source with 37 years of journalistic excellence that breaks news daily on its website, LVB.com. It also publishes a print and online edition. In addition, Lehigh Valley Business publishes special focus sections and products throughout the year including Reader Rankings plus the yearly Book of Lists. It also hosts eight annual events, including Women of Influence, Icon Honors and Forty Under 40, to recognize excellence and provide leadership opportunities. Lehigh Valley Business facilitates thoughtful discussion with market leaders through its webinar series. Its Digital Marketing Solutions helps customers with social media, search engine marketing and optimization, retargeting, email marketing and more.

Media Contact

Kelsey Brett, MyAdvisor, 1 8142159248, [email protected], www.myadvisor.healthcare

LinkedIn

SOURCE MyAdvisor

Tatango Partners with Nuclavis to Reveal Mobile-First Peer-to-Peer Fundraising Strategy in the Post-COVID Era in Innovative Whitepaper


The whitepaper emphasizes the power of personalization, data-driven insights, and seamless integration between text messaging and mobile apps to empower nonprofits.

RALEIGH, N.C., Oct. 10, 2023 /PRNewswire-PRWeb/ — Tatango, the leading text message platform in the nonprofit sector, has partnered with Nuclavis, a digital marketing and mobile software company focused on nonprofits, in the creation and publication of a whitepaper entitled, “Winning Mobile-First Peer-to-Peer Strategy to Engage Participants and Maximize Fundraising.”

The COVID-19 pandemic caused a 34 percent decline in revenue for the top 30 peer-to-peer programs. The proposed strategy in this whitepaper aims to bridge the $220 million gap that continues to exist today by providing cost-effective alternatives to traditional outreach methods, ensuring real-time engagement with participants and the rise of smartphone usage.

Tatango and Nuclavis aim to advance peer-to-peer fundraising strategies and provide guidance for nonprofits adapting to the post-COVID landscape. The whitepaper emphasizes the significance of utilizing text messaging and mobile applications for participant engagement and fundraising optimization. This approach integrates real-time engagement, cost-effectiveness, and personalized interactions to enhance participant involvement and fundraising efforts.

“We are excited to collaborate with Nuclavis and present insights showing nonprofits that when adding a mobile app and text messaging, the digital fundraising toolkit is ready to deliver big results. By meeting participants on their phones, we can ensure urgent communications are noticed and acted upon, in turn helping nonprofits meet their fundraising goals,” said Geoff Alexander, Tatango’s Chief Marketing Officer.

“With a mobile-first strategy, nonprofits can meet their constituents where they are. With a comprehensive mobile combination of texting and a mobile app, nonprofits can optimize user engagement, improve communication, and maximize fundraising.” said Kathy Kempff Nuclavis Founder and Chief Executive Officer, “We’re thrilled to partner with Tatango, bringing leading-edge mobile technology to the nonprofit sector.”

This whitepaper is anticipated to have a significant impact on the peer-to-peer fundraising landscape, providing nonprofits with valuable insights to navigate and excel in an evolving digital environment.

On October 18, 2023, at 11 AM CST/12 PM ET, Tatango and Nuclavis are hosting a webinar to share the contents of the whitepaper in a session called “Unlocking the Power of Mobile“.

Media Contact

Amanda Speer, Tatango, 1 9196059280, [email protected], tatango.com 

SOURCE Tatango

Citeline’s Marketing Insights, the Catalyst for Innovative Pharma Marketing Solutions


Citeline announces the relaunch of Pharma Ignite, its marketing insights division previously known as Pharma Intelligence Marketing Services, supporting pharmaceutical and life sciences suppliers across the entire product life cycle.

NEW YORK, Oct. 10, 2023 /PRNewswire-PRWeb/ — Citeline announces the relaunch of Pharma Ignite, its marketing insights division previously known as Pharma Intelligence Marketing Services, supporting pharmaceutical and life sciences suppliers across the entire product life cycle. The Pharma Ignite team of content and marketing experts continues to deliver cutting-edge thought leadership, lead-generation and awareness campaigns, enabling companies to connect with their target audience and solidify their position in the marketplace.

With extensive experience in crafting tailored marketing strategies and events, the Pharma Ignite team collaborates closely with clients to design and execute strategies that drive commercial success. This includes extending audience outreach through Citeline’s suite of world-renowned publications, including Scrip, Pink Sheet and In Vivo.

Pharma Ignite brings together Citeline’s industry-leading analysts, editors, and partners as well as those of the wider Norstella group to deliver insights, content and transformative marketing solutions. The rebrand to Pharma Ignite reflects Norstella’s commitment to support innovation and expansion across all areas of the business and drug development pipeline.

“Pharma Ignite is the next step in our evolution to connect pharma suppliers with their biopharma customers,” said Chris Crucitti, Chief Revenue Officer of Citeline. “For our client partners, standing out as a provider in this space is harder than ever, so we have combined our market-leading insights, our best-in-class content creation and our event expertise to help suppliers identify and access senior biopharma decision makers. This allows our partners to engage, differentiate and showcase their solutions, helping them retain and attract the right customers. It’s all part of our mission to solve complex problems and guide the industry to accelerate the path from pipeline to patient.”

From qualified marketing leads to enhanced brand awareness, custom content and in-depth marketing intelligence, at the core of Pharma Ignite’s approach is a commitment to deliver results. Leveraging Citeline’s global subscribers, products and services, the team connects suppliers to the pharmaceutical, biotech and medtech industry. Covering the breadth of the drug development life cycle, Pharma Ignite enables CROs, CDMOs, tech firms and other pharma industry suppliers to identify and engage with current and new customers.

For more information about Pharma Ignite, visit citeline.com/ignite.

About Pharma Ignite

Pharma Ignite is the dynamic marketing insights division of Citeline, offering tailored marketing solutions to businesses within the pharmaceutical and life sciences industry. Leveraging Citeline’s world-class suite of products and services, Pharma Ignite specializes in lead generation, thought leadership, and brand awareness utilizing a range of solutions including custom content, events, digital advertising, research and marketing campaigns. For more information, visit Citeline.com/ignite.

About Citeline

Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.

Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline and follow on LinkedIn and Twitter.

Media Contact

Sophia Steinhorn, Diffusion PR for Citeline, 1 213-318-4500, [email protected], https://www.citeline.com 

SOURCE Citeline



Options Medical Weight Loss Announces Rescheduled Grand Opening in Fishers, Indiana


Options Medical Weight Loss is committed to helping individuals achieve their health and wellness goals through safe, effective, and customized weight loss programs. Options has helped over 50,000 people on their weight loss journey and looks forward to bringing that expertise to the Central Indiana region. The Fishers clinic will offer a range of services, including medically supervised weight loss and weight loss health coaching.

“After recently analyzing data of our patients over the past 10 years, we’ve found the average Options patient is significantly changing their body composition over a 6 month period. Increasing a patient’s muscle to fat ratio is a notable benefit to long-term health,” said Dr. Katrina Mattingly, Chief Medical Officer of Options Medical Weight Loss. “We pride ourselves on looking beyond the number on the scale. In 6 months, our average patient is losing 30lbs of fat, including 21% of their dangerous visceral fat and 17% of their total body weight. At Options Medical Weight Loss we support and encourage our patients to a deeper level of health.”

The Grand Opening event will feature a ribbon-cutting ceremony, facility tours, free consultations with our weight loss specialists, and exclusive offers for attendees.

Options Medical Weight Loss invites residents of Fishers, Carmel, Noblesville, Saxony Village, Hamilton Proper, Pendleton, Lawrence, and surrounding communities to join us for this momentous occasion.

Options Medical Weight Loss is driven by a purpose to reduce the year over year growth rate of obesity through positive, life-changing experiences. The Options team knows weight loss is much more than fitting into certain clothes. Weight loss can have a positive impact on certain health conditions such as heart disease and diabetes, and hopefully lead to a healthier, happier, and longer life.

For more information about Options Medical Weight Loss or to schedule a free consultation, please visit the Fishers website or contact 888-405-LOSE (5673).

About Options Medical Weight Loss:
Options Medical Weight Loss is a trusted provider of customized, medically supervised weight loss programs. With a commitment to patient success and a team of dedicated healthcare professionals, Options Medical Weight Loss empowers individuals to achieve their weight loss goals safely and effectively.

Media Contact

Stephanie Wright, Options Medical Weight Loss, 888-405-5673, [email protected], https://optionsmedicalweightloss.com/locations/indiana/fishers-weight-loss-clinic/

SOURCE Options Medical Weight Loss